|
|
 |
 |
 |
 |
 |
 |
ganiMed focuses its services to be rendered primarily to the field of central analysis of externally recorded ECG data (Rest ECG, Stress Test ECG, Holter), to reveal to our customers the side-effects possibly connected with the ECG data in the field of physiological cardiac excitation, so that corrective measures can be started at an early stage. The ongoing access to the data is generally possible on request and is often desired in the studies mentioned below:
QT-Prolongation
Intensive monitoring in phase II and III, if a signal is available
Increase of the daily dose in deviation to the defined substance
quantity
Placebo controlled group
Sex-specific differences which must be examined explicitly
|
 |
|
|
|
|
|
 |
|
|